Skip to main content
SpringerLink
Log in

A Review of Quality of Life in Alzheimer’s Disease

Part 1: Issues in Assessing Disease Impact

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

There are numerous methods available for assessing patients with Alzheimer’s disease (AD) or other forms of dementia. Quality-of-life (QOL) assessment is unique among these methods, because the QOL concept itself includes a subjective component that is fundamental to its measurement. It could be argued that measuring quality of life is just as important as measuring disease severity, disease progression, symptom response, cognition, behavioural disturbance and activities of daily living when assessing the impact of disease and intervention in dementia. The subjective nature of quality of life provides healthcare professionals with the opportunity of incorporating the value systems of patients and their carers into their assessments.

A systematic review was carried out to include the published data (and some unpublished data) on QOL assessment tools and instruments that claim to measure quality of life in dementia. Literature for this review was identified by a thorough search of computer databases (1980–1997) that included Medline, Embase, PsychLit and International Pharmaceutical Abstracts. Reports concerning the conceptualisation, development, validation, reliability, reproducibility, comprehensiveness, practicality and use of QOL instruments in dementia/AD were selected for review as well as papers documenting clinical drug trials in this therapeutic area.

A number of measures or methods used in the literature for assessing the quality of life of patients with dementing illnesses were identified. It was decided to present the resulting review in 2 parts that correspond to the 2 main groups into which the instruments were categorised. The first (part 1) looks at measures used to assess the impact of disease as well as instruments at a developmental or testing stage. The second (part 2) includes instruments that claim to measure quality of life in studies documenting the impact of a drug in this therapeutic area.

There are as yet no validated methods of assessing the quality of life of both patients with dementia and their carers at the same time. QOL outcomes for these 2 groups is closely, if not fundamentally, linked and yet most studies identified in this review concentrate on measuring the quality of life of either the patient or the carer alone. Although some researchers may be getting close conceptually, an instrument has yet to satisfy all the criteria necessary to become accepted as a gold standard for QOL assessment in dementing illness. The ideal instrument must show that it can reliably, reproducibly and comprehensively assess quality of life for patients with dementia and their carers. It should also demonstrate that it can measure quality of life effectively using a practical administration technique that does not place any unnecessary burden on either informal carers, other healthcare workers involved or the patient themselves. Further cross-sectional and longitudinal research is required to psychometrically test the available instruments as well as continuing conceptual research to explore new ways of assessing quality of life in this important area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tomlinson BE, Blessed G, Roth M. Observations on the brainsof demented old people. J Neurol Sci 1970; 11: 205–42

    Article  PubMed  CAS  Google Scholar 

  2. Perry RH, Irving D, Blessed G, et al. Dementia in old age:identification of a clinically and pathologically distinct diseasecategory. In: Wurtman RJ, editor. Advances in neurology.Vol. 51: Alzheimer;s disease. New York: Raven Press,1990: 41–6

    Google Scholar 

  3. Royal College of Physicians Committee on Geriatrics. Reportof the Royal College of Physicians: organic mental impairmentin the elderly. J R Coll Physicians Lond 1981; 15:141–67

    Google Scholar 

  4. World Health Organization (WHO). The ICD-10 classificationof mental and behavioural disorders. Geneva: WHO, 1992

  5. American Psychiatric Association. Diagnostic and statisticalmanual of mental disorders. 4th ed. Washington, DC: AmericanPsychiatric Association, 1994

  6. Erkinjuntti T, Ostbye T, Steenhvis R, et al. The effect of differentdiagnostic criteria on the prevalence of dementia. N EnglJ Med 1997; 337: 1667–74

    Article  CAS  Google Scholar 

  7. Hofman A, Rocca WA, Brayne C, et al. The prevalence of dementiain Europe: a collaborative study of 1980-1990 findings.Int J Epidemiol 1991; 20: 736–48

    Article  PubMed  CAS  Google Scholar 

  8. Jorm AF, Korten AE, Henderson AS, et al. The prevalence ofdementia: a quantitative integration of the literature. ActaPsychiatr Scand 1987; 76: 465–79

    Article  PubMed  CAS  Google Scholar 

  9. Henderson J. Epidemiology of mental disorders and psychosocialproblems: dementia. Geneva: World Health Organization(WHO), 1994

    Google Scholar 

  10. Hagnell O, Lanke J, Rorsman B, et al. Current trends in theincidence of senile and multi-infarct dementia. A prospectivestudy of a total population followed over 25 years: TheLundby Study. Arch Psychiatr Nervenkr 1983; 233: 423–38

    Article  PubMed  CAS  Google Scholar 

  11. Kokmen E, Beard CM, O’Brien PC, et al. Epidemiology ofdementia in Rochester, Minnesota. Mayo Clin Proc 1996; 71:275–82

    Article  PubMed  CAS  Google Scholar 

  12. Bayer AJ. Recent progress in the management of Alzheimer’sdisease [clinical bulletin]. Geriatr Med 1994; 24(2): 1–4

    Google Scholar 

  13. Cooper B, Bickel H. Population screening and the early detectionof dementing disorders in old age: a review. Psychol Med1984; 14: 81–95

    Article  PubMed  CAS  Google Scholar 

  14. Bergmann K, Foster EM, Justice AW, et al. Management of thedemented elderly patient in the community. Br J Psychiatry1978; 132: 441–9

    Article  PubMed  CAS  Google Scholar 

  15. Folstein MF. Differential diagnosis of dementia: the clinicalprocess. Psychiatr Clin North Am 1997; 20: 45–57

    Article  PubMed  CAS  Google Scholar 

  16. Kluger A, Ferris SH. Scales for the assessment of Alzheimer’sdisease. Psychiatr Clin North Am 1991; 14: 309–26

    PubMed  CAS  Google Scholar 

  17. Morgan CD, Baade LE. Neuropsychological testing and assessmentscales for dementia of the Alzheimer’s type. PsychiatrClin North Am 1997; 20: 25–43

    Article  PubMed  CAS  Google Scholar 

  18. Ferris SH, Kluger A. Assessing cognition in Alzheimer’s diseaseresearch. Alzheimer Dis Assoc Disord 1997; 11 Suppl.6: 45–9

    Google Scholar 

  19. Ferris SH, Lucca U, Mohs R, et al. Objective psychometric testsin clinical trials of dementia drugs. Alzheimer Dis Assoc Disord1997; 11 Suppl. 3: 34–8

    Google Scholar 

  20. Weiner MF, Koss E, Wild KV, et al. Measures of psychiatricsymptoms in Alzheimer patients: a review. Alzheimer DisAssoc Disord 1996; 10: 20–30

    PubMed  CAS  Google Scholar 

  21. Ferris SH, Mackell JA. Behavioural outcomes in clinical trialsfor Alzheimer disease. Alzheimer Dis Assoc Disord 1997; 11Suppl. 4: S10–5

  22. Cummings JL. Changes in neuropsychiatric symptoms as outcomemeasures in clinical trials with cholinergic therapies forAlzheimer disease. Alzheimer Dis Assoc Disord 1997; 11Suppl. 4: S1–9

    Google Scholar 

  23. Teunisse S. Activities of daily living scales in dementia: theirdevelopment and future. In: Levy R, Howard R, editors.Developments in dementia and functional disorders in theelderly. Petersfield, Hampshire: Wrightson Biomedical Publishing,1995

    Google Scholar 

  24. Reisberg B, Schneider L, Doody R, et al. Clinical global measuresof dementia. Alzheimer Dis Assoc Disord 1997; 11Suppl. 3: 8–18

    Google Scholar 

  25. Clipp EC, Moore MJ. Caregiver time use: an outcome measurein clinical trial research on Alzheimer’s disease. Clin PharmacolTher 1995; 58: 228–36

    Article  PubMed  CAS  Google Scholar 

  26. Baumgarten M. The health of persons giving care to the dementedelderly: a critical review of the literature. J ClinEpidemiol 1989; 42(12): 1137–48

    Article  PubMed  CAS  Google Scholar 

  27. Roth M, Huppert FA, Tym E, et al. CAMDEX: the CambridgeExamination for Mental Disorders in the Elderly. Cambridge: Cambridge University Press, 1988

    Google Scholar 

  28. Walker SR. Industry perspectives on quality of life. In: Walker SR, Rossor RM, editors. Quality of life assessment: key issuesin the 1990s. London: Kluwer Academic Publishers, 1993: 383

    Chapter  Google Scholar 

  29. World Health Organization (WHO) Quality-of-Life (QOL)group. World Health Organization quality of life-100. Geneva: WHO Division of Mental Health, 1995

  30. Ramsay M, Winget C, Higginson I. Review: measures to determinethe outcome of community services for people with dementia.Age Ageing 1995; 24: 73–83

    Article  PubMed  CAS  Google Scholar 

  31. Whitehouse PJ, Orgogozo JM, Becker RE, et al. Quality-of-lifeassessment in dementia drug development. Alzheimer DisAssoc Disord 1997; 11 Suppl. 3: 56–60

    Google Scholar 

  32. Zimmerman SI, Magaziner J. Methodological issues in measuringthe functional status of cognitively impaired nursing homeresidents: the use of proxies and performance-based measures.Alzheimer Dis Assoc Disord 1994; 8 Suppl. 1: S281–90

    Google Scholar 

  33. Rabins PV, Mace HL, Lucas MJ. The impact of dementia on thefamily. JAMA 1982; 248: 333–5

    Article  PubMed  CAS  Google Scholar 

  34. Levin E, Sinclair I, Gorbach P. Families, services and confusionin old age. Aldershot: Gower Publishing Group, 1989: 1–328

    Google Scholar 

  35. Clipp EC, George LK. Dementia and cancer: a comparison ofspouse caregivers. Gerontologist 1993; 33(4): 534–41

    Article  PubMed  CAS  Google Scholar 

  36. Jaeschke R, Guyatt GH. How to develop and validate a newquality of life instrument. In: Spilker B, editor. Quality of lifeassessments in clinical trials. 1st ed. New York: Raven Press,1990: 47–57

    Google Scholar 

  37. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validatea new health-related quality of life instrument. In: SpilkerB, editor. Quality of life and pharmacoeconomics in clinicaltrials. 2nd ed. Philadelphia (PA): Lippincott-Raven Publishers,1996: 49–56

    Google Scholar 

  38. Bergner M, Bobbitt RA, Kressel S, et al. The Sickness ImpactProfile: conceptual formulation and methodology for the developmentof a health status measure. Int J Health Serv 1976;6: 393–415

    Article  PubMed  CAS  Google Scholar 

  39. Bergner M, Bobbitt RA, Carter WB, et al. The Sickness ImpactProfile: development and final revision of a health status measure.Med Care 1981; 19: 787–805

    Article  PubMed  CAS  Google Scholar 

  40. Krenz C, Larson EB, Buchner DM, et al. Characterizing patientdysfunction in Alzheimer’s-type dementia. Med Care 1988;26: 453–61

    Article  PubMed  CAS  Google Scholar 

  41. Gerety MB, Cornell JE, Mulrow CD, et al. The Sickness ImpactProfile for Nursing Homes (SIP-NH). J Gerontol: MedicalSciences 1994; 49(1): M2–8

    CAS  Google Scholar 

  42. Salek MS. Development, validation and clinical application ofa health-related quality of life instrument [thesis]. Cardiff: University of Wales, 1990

    Google Scholar 

  43. Salek MS, Thomas S, Luscombe DK, et al. The impact of memoryclinic assessment on the quality of life of patients withcognitive decline: sensitivity of the UK Sickness Impact Profile[abstract]. Pharm World Sci 1993; 15 Suppl. G: G15

    Google Scholar 

  44. Salek MS, Griffith AR, Spiller C, et al. Assessment of qualityof life in patients with dementia: which measure [abstract]?Pharm World Sci 1994; 16 Suppl. G: G12

    Google Scholar 

  45. Salek MS, Walker MD. Quality of life assessment by communitypharmacists: its practicality in providing pharmaceuticalcare [abstract]. Pharm J 1995; 255(6868): R28

    Google Scholar 

  46. O’Boyle CA. The Schedule for the Evaluation of IndividualQuality of Life (SEIQoL). Int J Ment Health 1994; 23: 3–23

    Google Scholar 

  47. O’Boyle CA. The Schedule for the Evaluation of IndividualQuality of Life (SEIQOL): administration manual. Dublin: Royal College of Surgeons in Ireland, 1993

    Google Scholar 

  48. Meier D, Hiltbrunner B, Joyce CRB, et al. Assessment of individualquality of life in geriatric patients [abstract]. The XVthCongress of the International Association of Gerontology;1993 Jul 4; Budapest

    Google Scholar 

  49. Coen R, O’Mahony D, O’Boyle C, et al. Measuring the quality of life of patients with dementia using the Schedule for theEvaluation of Individual Quality of Life. Irish J Psychiatry1993; 14: 154–63

    Google Scholar 

  50. Kaplan RM, Bush JW, Berry CC. Health status: types of validityand the Index of Well-Being. Health Serv Res 1976; 11:478–507

    PubMed  CAS  Google Scholar 

  51. Kaplan RM, Bush JW. Health-related quality of life measurementfor evaluation research and policy analysis. Health Psychol1982; 1: 61–80

    Article  Google Scholar 

  52. Fanshel S, Bush JW. A Health-Status Index and its applicationto health-services outcomes. Oper Res 1970; 18: 1021–65

    Article  Google Scholar 

  53. Wimo A, Mattson B, Krakau I, et al. Cost-utility analysis ofgroup living in dementia care. Int J Technol Assess Health Care 1995; 11: 49–65

    Article  PubMed  CAS  Google Scholar 

  54. Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36health survey questionnaire: new outcome measure for primarycare. BMJ 1992; 305: 160–4

    Article  PubMed  CAS  Google Scholar 

  55. Jenkinson C, Wright L, Coulter A. Quality of life measurementin health care: a review of measures, and population normsfor the UK SF-36. Oxford: Health Services Research Unit,Department of Public Health and Primary Care, University ofOxford, 1993

    Google Scholar 

  56. Parker SG, Peet SM, Jagger C, et al. Measuring health status inolder patients. the SF-36 in practice. Age Ageing 1998; 27:13–8

    Article  PubMed  CAS  Google Scholar 

  57. Hill S, Harries U, Popay J. Is the short form 36 (SF-36) suitablefor routine health outcomes assessment in health care for olderpeople? Evidence from preliminary work in community basedhealth services in England. J Epidemiol Community Health1996; 50: 94–8

    Article  PubMed  CAS  Google Scholar 

  58. Brazier JE, Walters SJ, Nicholl JP, et al. Using the SF-36 andEuroqol on an elderly population. Qual Life Res 1996; 5:195–204

    Article  PubMed  CAS  Google Scholar 

  59. Uhlmann R, Pearlman R. Perceived quality of life and preferencesfor life-sustaining treatment in older adults. Arch InternMed 1991; 151: 495–7

    Article  PubMed  CAS  Google Scholar 

  60. Pearlman R, Uhlmann R. Patient and physician perceptions ofpatient quality of life in chronic diseases. J Gerontol 1988;43: M25–30

    PubMed  CAS  Google Scholar 

  61. Mezey M, Kluger M, Maislin G, et al. Life-sustaining treatmentdecisions by spouses of patients with Alzheimer’s disease. JAm Geriatr Soc 1996; 44: 144–50

    CAS  Google Scholar 

  62. Pearlman RA, Uhlmann RF. Quality of life in elderly, chronicallyill outpatients. J Gerontol 1991; 46: M31–8

    PubMed  CAS  Google Scholar 

  63. Byrne H, MacLean D. Quality of life: perceptions of residentialcare. Int J Nurs Pract 1997; 3: 21–8

    PubMed  CAS  Google Scholar 

  64. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: apractical method for grading the cognitive state of patients forthe clinician. J Psychiatr Res 1975; 12: 189–98

    Article  PubMed  CAS  Google Scholar 

  65. Blessed G, Tomlinson BF, Roth M. The association betweenquantitative measures of dementia and of senile change in thecerebral grey matter of elderly subjects. Br J Psychiatry 1968;114: 797–811

    Article  PubMed  CAS  Google Scholar 

  66. Sano M, Bell K, Cote L, et al. Double-blind parallel design pilotstudy of acetyl levocarnitine in patients with Alzheimer’s disease. Arch Neurol 1992; 49: 1137–41

    Article  PubMed  CAS  Google Scholar 

  67. Reisberg B, Ferris SH, de Leon MJ, et al. The Global DeteriorationScale for assessment of primary degenerative dementia.Amer J Psychiatry 1982; 139: 1136–9

    CAS  Google Scholar 

  68. Ware JE, Sherbourne CD. The MOS 36-item Short-Form healthstatus survey 1: conceptual framework and item selection.Med Care 1992; 30: 473–83

    Google Scholar 

  69. Ware JE, Snow KK, Kosinski M, et al. SF-36 health surveymanual and interpretation guide. Boston: New England MedicalCentre, The Health Institute, 1993

    Google Scholar 

  70. EuroQOL Group. Euroqol:a new facility for the measurement ofhealth-related quality of life. Health Policy 1990; 16: 199–208

    Article  Google Scholar 

  71. Dejong R, Osterlund OW, Roy GW. Measurement of quality oflife changes in patients with Alzheimer’s disease. Clin Ther1989; 11: 545–54

    PubMed  CAS  Google Scholar 

  72. Brod M, Stewart A, Sands L, et al. The Dementia Quality ofLife Rating Scale (D-QoL) [abstract]. Gerontologist 1996; 36 (Special Issue 1): 257

    Google Scholar 

  73. Logsdon RG.Quality of life in Alzheimer’s disease: implicationsfor research [abstract]. Gerontologist 1996; 36(SpecialIssue 1): 278

    Google Scholar 

  74. Salek MS, Schwartzberg E, Bayer AJ. Evaluating health-relatedquality of life in patients with dementia: development of aproxy self-administered questionnaire [abstract]. Pharm World Sci 1996; 18(5 Suppl. A): 6

    Google Scholar 

  75. Salek MS, Ramgoolam N, Edwards SA, et al. Quality of lifeassessment in Alzheimer’s disease: reliability of a dementiaspecificmeasure (CDQLP). The 26th Symposium on ClinicalPharmacy, European Society of Clinical Pharmacy; 1997 Oct15-17; Tours, France, 48

    Google Scholar 

  76. Albert SM, Del Castillo-Castaneda C, Sano M, et al. Quality oflife in patients with Alzheimer’s disease as reported by patientproxies. J Am Geriatr Soc 1996; 44: 1342–7

  77. DeLetter MC, Tully CL, Wilson JF, et al. Nursing staff perceptionsof quality of life of cognitively impaired elders: Instrumentaldevelopment. J Appl Gerontol 1995; 14: 426–43

    Article  Google Scholar 

  78. Lawton MP, Brody EM. Assessment of older people: self-maintainingand instrumental activities of daily living. Gerontologist1969; 9: 176–86

    Google Scholar 

  79. Davis KL, Thal LJ, Gamzu ER, et al. A double-blind, placebocontrolledmulticenter study of tacrine for Alzheimer’s disease.N Engl J Med 1992; 327: 1253–9

    Article  PubMed  CAS  Google Scholar 

  80. Farlow M, Gracon SI, Hershey LA, et al. A controlled trial oftacrine in Alzheimer’s disease. JAMA 1992; 268: 2523–9

    Article  PubMed  CAS  Google Scholar 

  81. Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomizedcontrolled trial of high-dose tacrine in patients withAlzheimer’s disease. JAMA 1994; 271: 985–91

    Article  PubMed  CAS  Google Scholar 

  82. Vincent SA, Harvey RJ. The ADENA programme. Clinical advancesin drug development: Alzheimer’s disease trial design.Sevenoaks: Medpress, 1998

    Google Scholar 

  83. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recentevidence and development of a shorter version. In: BrinkTL, editor. Clinical gerontology: a guide to assessment andintervention. New York: Haworth Press, 1986: 165–74

  84. Hamilton M. Development of a rating scale for primary depressiveillness. Br J Soc Clin Psychol 1967; 6: 278–96

    Google Scholar 

  85. Hamilton M. A rating scale for depression. J Neurol NeurosurgPsychiatry 1960; 23: 56–62

    Article  PubMed  CAS  Google Scholar 

  86. Yesavage JA, Brink TL, Rose TL, et al. Development and validationof a geriatric depression screening scale: a preliminaryreport. J Psychiatr Res 1983; 17: 37–49

    Article  CAS  Google Scholar 

  87. Teri L, Logsdon RG. Identifying pleasant activities for Alzheimer’sdisease patients: the pleasant events schedule-AD.Gerontologist 1991; 31: 124–7

    Article  PubMed  CAS  Google Scholar 

  88. Lawton MP. Quality of life in Alzheimer’s disease. AlzheimerDis Assoc Disord 1994; 8 Suppl. 3: 138–50

    Google Scholar 

  89. Erickson P, Wilson RW, Seitz F, et al. Years of healthy life: ameasure of healthy life span for Health People 2000. In: Proceedingsof the 1993 Public Health Conference on Recordsand Statistics. Bethseda (MD): Centers for Disease Controland Prevention, 1993: 21–7

    Google Scholar 

  90. Stern Y, Sano M, Paulson J, et al. Modified mini-mental stateexamination: validity and reliability [abstract]. Neurology 1987; 37 Suppl. 1: 179

    Google Scholar 

  91. Lawton MP. The Philadelphia Geriatric Center Morale Scale: arevision. J Gerontol 1975; 30(1): 85–9

    PubMed  CAS  Google Scholar 

  92. Ekman P, Friesen WV. Facial action coding system. Palo Alto(CA): Consulting Psychologists Press, 1978

    Google Scholar 

  93. MacDonald AJD, Craig TKJ, Warner LAR. The developmentof a short observation method for the study of activity andcontacts of old people in residential settings. Psychol Med1985; 15: 167–72

    Article  PubMed  CAS  Google Scholar 

  94. Wills W, Leff J. The TAPS Project 30: quality of life for elderlymentally ill patients. A comparison of hospital and communitysettings. Int J Geriatr Psychiatry 1996; 11: 953–63

    Article  Google Scholar 

  95. Dean R, Briggs K, Lindesay J. The domus philosophy: a prospectiveevaluation of two residential units for the elderlymentally ill. Int J Geriatr Psychiatry 1993; 8: 807–17

    Article  Google Scholar 

  96. Dean R, Proudfoot R, Lindesay J. The quality of interactionsschedule (QUIS): development, reliability and use in the evaluationof two domus units. Int J Geriatr Psychiatry 1993; 8:819–26

    Article  Google Scholar 

  97. Skea D, Lindesay J. An evaluation of two models of long-termresidential care for elderly people with dementia. Int J GeriatrPsychiatry 1996; 11: 233–41

    Article  Google Scholar 

  98. Kitwood T, Bredin K. A new approach to the evaluation ofdementia care. J Adv Health Nurs Care 1992; 1: 41–60

    Google Scholar 

  99. Bredin K, Kitwood T, Wattis J. Decline in quality of life forpatients with severe dementia following a ward merger. Int JGeriatr Psychiatry 1995; 10: 967–73

    Article  Google Scholar 

  100. Williams J, Rees J. The use of ‘dementia care mapping’ as amethod of evaluating care received by patients with dementia-An initiative to improve quality of life. J Adv Nurs 1997;25: 316–23

    Article  PubMed  CAS  Google Scholar 

  101. Godlove C, Richard L, Rodwell G. Time for action: an observationstudy of elderly people in four different care environ Services Research, Social Services Monographs, Research in Practice, 1981

  102. Kitwood T, Bredin K. Evaluating dementia care: the DCMmethod. 6th ed. Bradford: Bradford Dementia ResearchGroup, 1994

    Google Scholar 

  103. Wells Y, Jorm AF. Evaluation of a special nursing home unit fordementia sufferers: a randomised controlled comparison withcommunity care. Aust N Z J Psychiatry 1987; 21: 524–31

    Article  PubMed  CAS  Google Scholar 

  104. Draper BM, Poulos CJ, Cole AMD, et al. A comparison of caregiversfor elderly stroke and dementia victims. J Am GeriatrSoc 1992; 40: 896–901

    PubMed  CAS  Google Scholar 

  105. Draper BM, Poulos RG, Poulos CJ, et al. Risk factors for stressin elderly caregivers. Int J Geriatr Psychiatry 1995; 11: 227–31

    Article  Google Scholar 

  106. Goldberg DP. The detection of psychiatric illness by questionnaire.London: Oxford University Press, 1972107. Jerrom B, Mian I, Rukanyake NG, et al. Stress on relative caregiversof dementia sufferers, and predictors of the breakdownof community care. Int J Geriatr Psychiatry 1993; 8:331–7

    Article  Google Scholar 

  107. Jerrom B, Mian I, Rukanyake NG, et al. Stress on relative caregivers of dementia sufferers, and predictors of the breakdown of community care. Int J Geriatr Psychiatry 1993; 8: 331–7

    Article  Google Scholar 

  108. Goodchild ME, Duncan-Jones P. Chronicity and the GeneralHealth Questionnaire. Br J Psychiatry 1985; 146: 56–61

    Article  Google Scholar 

  109. Goldberg DP, Hillier VF. A scaled version of the General HealthQuestionnaire. Psychol Med 1979; 9: 139–45

    Article  PubMed  CAS  Google Scholar 

  110. O’Connor DW, Pollitt PA, Roth M, et al. Problems reported byrelatives in a community study of dementia. Br J Psychiatry1990; 156: 835–41

    Article  PubMed  Google Scholar 

  111. Hinchliffe AC, Livingstone G. Carers of people with dementia:can their mental health be improved? Prim Care Psychiatry1995; 1: 249–54

    Google Scholar 

  112. Mohide EA, Torrance GW, Streiner DL, et al. Measuring thewell-being of family caregivers using the time trade-off technique.J Clin Epidemiol 1988; 41: 475–82

    Article  PubMed  CAS  Google Scholar 

  113. Shulman KI, Cohen CA. Quality of Life and economic aspectsof community support programs for caregivers of dementiapatients. Am J Geriatr Psychiatry 1993; 1: 211–20

    Article  Google Scholar 

  114. Torrance GW. Utility approach to measuring health-relatedquality of life. J Chronic Dis 1987; 40: 593–600

    Article  PubMed  CAS  Google Scholar 

  115. Kerner DN, Patterson DL, Grant J, et al. Validity of the Qualityof Well-Being Scale for patients with Alzheimer’s disease. JAging Health 1998; 10: 44–61

    Article  CAS  Google Scholar 

  116. Albert SM, Marks J, Barrett V, et al. Home health care andquality of life of patients with Alzheimer’s disease. Am J PrevMed 1997; 13: 63–8

    PubMed  CAS  Google Scholar 

  117. Royal College of Physicians/British Geriatrics Society (RCP/-BGS). Standardised assessment scales for elderly people.London: RCP/BGS, 1992

  118. Kane RA, Kane RL. Assessing the elderly: a practical guide tomeasurement. Lexington (MA): Lexington Books, 1981

    Google Scholar 

  119. Nagatomo I, Kita K, Takigawa M, et al. A study of the qualityof life in elderly people using psychological testing. Int JGeriatr Psychiatry 1997; 12: 599–608

    Article  CAS  Google Scholar 

  120. Maeda D, Noguchi Y, Tamano K, et al. The structure and factorsof life satisfaction in the elderly [in Japanese]. Shakai RonenGaku 1989; 30: 3–16

    Google Scholar 

  121. Spitzer WO. State of science 1986: quality of life and functionalstatus as target variable for research. J Chronic Dis 1987; 40:465–72

    Article  PubMed  CAS  Google Scholar 

  122. Whitehouse PJ. Pharmacoeconomics of dementia. AlzheimerDis Assoc Disord 1997; 11 Suppl. 5: S22–33

    Google Scholar 

  123. Rabins PV, Kasper J, Kleinman L, et al. Developing a scale tomeasure quality of life in persons with dementia [abstract].Implications for Research Symposium: Quality of Life in Alzheimer’sDisease: 1996 Nov 20; Seattle, 1996

    Google Scholar 

  124. Kosberg JI, Cairl RE, Keller DM. Components of burden: interventiveimplications. Gerontologist 1990; 30: 236–42

    Article  PubMed  CAS  Google Scholar 

  125. Vitaliano PP, Russo J, Young HM, et al. The screen for caregiverburden. Gerontologist 1991; 31: 76–83

    Article  PubMed  CAS  Google Scholar 

  126. Donaldson C, Tarrier N, Burns A. The impact of the symptomsof dementia on caregivers. Br J Psychiatry 1997; 170: 62–8

    Article  PubMed  CAS  Google Scholar 

  127. George LK, Gwyther LP. Caregiver well-being: a multidimensionalexamination of family caregivers of demented adults. Gerontologist 1986; 26: 253–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medicines Research Unit, Division of Clinical Pharmacy, University of Wales, Cardiff, Wales

    Melvyn D. Walker &  Sam S. Salek

  2. Department of Geriatric Medicine, University of Wales College of Medicine, Cardiff, Wales

    Antony J. Bayer

Authors
  1. Melvyn D. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sam S. Salek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antony J. Bayer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sam S. Salek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walker, M.D., Salek, S.S. & Bayer, A.J. A Review of Quality of Life in Alzheimer’s Disease. Pharmacoeconomics 14, 499–530 (1998). https://doi.org/10.2165/00019053-199814050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199814050-00004

Keywords

Search

Navigation